H.D. Smith veteran Joe Conda tapped for NACDS Pratt Award at pharmacy conference
SAN DIEGO —The National Association of Chain Drug Stores tapped wholesale and pharmaceutical industry veteran Joe Conda for its highest honor, the Harold W. Pratt Award, to close out its 2010 Pharmacy and Technology Conference here.
The award, named for longtime Walgreens pharmacy leader Harold Pratt, was given in recognition of Conda’s four decades of leadership in pharmacy, according to NACDS. The honor was established in 1985 by the NACDS board to recognize individuals “whose activities have contributed to the promotion, recognition and improvement of the practice of pharmacy within the chain drug industry,” according to the organization.
Conda is SVP strategic planning for pharmaceutical wholesaler H.D. Smith, charged with managing the company’s strategic development process, translating opportunities into measurable objectives and assisting senior executive leadership with long-term planning. Prior to joining H.D. Smith, Conda consulted for pharmaceutical, consumer packaging and medical technology companies.
Previously, he served as president of Owens Illinois Healthcare Packaging, and also served in sales and marketing capacities at Brockway.
“We are pleased to honor Joe’s 40 years of dedicated service to the pharmacy industry by bestowing upon him the Harold W. Pratt Award,” said NACDS president and CEO Steve Anderson, who honored Conda at the annual pharmacy conference’s final reception and dinner Aug. 31. “Joe has spent his time building relationships and building strategy. He has forged relationships among many groups that benefited not only his company, but also the industry. He has helped shape pharmacy into what it has become today, and helped to create the momentum that will continue to enhance pharmacy’s role in healthcare delivery.”
Pfizer recalls lot of ThermaCare HeatWraps Menstrual
NEW YORK Pfizer’s over-the-counter division recalled one lot of a ThermaCare product over the possibility of leaks.
Pfizer Consumer Healthcare announced Friday the voluntary recall of lot number E06931 of its ThermaCare HeatWraps Menstrual product and notified the Food and Drug Administration.
The company said possible leaks in the wraps could cause skin injury, such as irritation and burning.
AstraZeneca-Bristol drug just as effective as generic on market, trial results show
STOCKHOLM An investigational diabetes drug works as well as a generic already on the market, according to results of a late-stage clinical trial announced Friday by AstraZeneca and Bristol-Myers Squibb.
The two companies said phase-3 trial results showed that their investigational drug dapagliflozin combined with the widely available generic metformin was as effective as glipizide combined with metformin, compared with metformin alone. In addition, patients in the dapagliflozin group experienced weight loss, compared with weight gain in those taking glipizide, as well as a reduced number of patients experiencing abnormally low blood sugar, known as hypoglycemia.
Results from the study were presented at the 46th annual meeting of the European Association for the Study of Diabetes.